Mar 31, 2019

ANI Pharmaceuticals Q1 2019 Earnings Report

Total Revenue
$52.9M
Previous year: $46.5M
+13.8%
EPS
$1.3
Previous year: $1.32
-1.5%
Gross Profit
$38.2M
Previous year: $25.8M
+48.0%
Cash and Equivalents
$38.2M
Previous year: $52M
-26.4%
Free Cash Flow
$12.5M
Previous year: $20.7M
-39.4%
Total Assets
$434M
Previous year: $418M
+3.9%

ANI Pharmaceuticals

ANI Pharmaceuticals

ANI Pharmaceuticals Revenue by Segment

Revenue & Expenses

Visualization of income flow from segment revenue to net income